Carlsmed names Richard Heppenstall CFO, replacing Leo Greenstein

By Public Technologies
  • Carlsmed named Richard Heppenstall chief financial officer, effective immediately, replacing Leo Greenstein, who is leaving to pursue other interests.
  • Heppenstall was CFO and treasurer at ZimVie from September 2021 until its October 2025 acquisition by ArchiMed.
  • He previously served as CFO at Breg, finance and treasury SVP at Orthofix, with earlier roles at Solera Holdings, Flowserve, CooperVision.
  • Full-year 2026 revenue guidance reaffirmed at $74 million to $78 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsmed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001794546-26-000020), on September 30, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.